from,to,fromCount,edgewidth
OM Adverse events,Bartelmaos et al (2013),1,1
OM Blood loss,Bartelmaos et al (2013),1,1
OM Coagulation factors ,Bartelmaos et al (2013),1,1
OM Fibrinogen,Bartelmaos et al (2013),1,1
OM Plasma,Bartelmaos et al (2013),1,1
OM Platelets,Bartelmaos et al (2013),1,1
OM PT,Bartelmaos et al (2013),1,1
OM RBC,Bartelmaos et al (2013),1,1
OM Thromboelastography ,Bindi et al (2013),1,1
OM aPTT,Bindi et al (2013),1,1
OM ATIII,Bindi et al (2013),1,1
OM Coagulation factors ,Bindi et al (2013),1,1
OM Complete Blood Count,Bindi et al (2013),1,1
OM Fibrinogen,Bindi et al (2013),1,1
OM INR,Bindi et al (2013),1,1
OM Adverse events,Carson JL et al (2021),1,1
OM Complete Blood Count,Carson JL et al (2021),1,1
OM Complete Blood Count,Carson JL et al (2021),1,1
OM INR,Carson JL et al (2021),1,1
OM LOS ICU,Carson JL et al (2021),1,1
OM Plasma,Carson JL et al (2021),1,1
OM Platelets,Carson JL et al (2021),1,1
OM RBC,Carson JL et al (2021),1,1
OM Transfusion reaction,Carson JL et al (2021),1,1
OM aPTT,Chong Sung et al (2006),1,1
OM Blood loss,Chong Sung et al (2006),1,1
OM Complete Blood Count,Chong Sung et al (2006),1,1
OM Death,Chong Sung et al (2006),1,1
OM FFP,Chong Sung et al (2006),1,1
OM HCT,Chong Sung et al (2006),1,1
OM INR,Chong Sung et al (2006),1,1
OM RBC,Chong Sung et al (2006),1,1
OM Reoperation,Chong Sung et al (2006),1,1
CA Death,D 1 Mortality and Survival,1,1
CA Death,D 1 Mortality and Survival,1,1
CA Death,D 1 Mortality and Survival,1,1
CA Death,D 1 Mortality and Survival,1,1
CA Death,D 1 Mortality and Survival,1,1
CA Death,D 1 Mortality and Survival,1,1
CA Death,D 1 Mortality and Survival,1,1
CA Death,D 1 Mortality and Survival,1,1
CA Death,D 1 Mortality and Survival,1,1
CA Death,D 1 Mortality and Survival,1,1
CA Death,D 1 Mortality and Survival,1,1
CA Death,D 1 Mortality and Survival,1,1
CA Death,D 1 Mortality and Survival,1,1
CA Death,D 1 Mortality and Survival,1,1
CA Physiological,D 11 Immune system outcomes,1,1
CA Clinical,D 17 Nervous system outcomes,1,1
CA Clinical,D 17 Nervous system outcomes,1,1
CA Clinical,D 17 Nervous system outcomes,1,1
CA Clinical,D 17 Nervous system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 2 Blood and lymphatic system outcomes,1,1
CA Physiological,D 22 Respiratory thoracic and mediastinal outcomes,1,1
CA Physiological,D 22 Respiratory thoracic and mediastinal outcomes,1,1
CA Physiological,D 22 Respiratory thoracic and mediastinal outcomes,1,1
CA Clinical,D 24 Vascular outcomes,1,1
CA Clinical,D 24 Vascular outcomes,1,1
CA Clinical,D 24 Vascular outcomes,1,1
CA Clinical,D 24 Vascular outcomes,1,1
CA Clinical,D 24 Vascular outcomes,1,1
CA Clinical,D 24 Vascular outcomes,1,1
CA Clinical,D 24 Vascular outcomes,1,1
CA Clinical,D 24 Vascular outcomes,1,1
CA Clinical,D 24 Vascular outcomes,1,1
CA Clinical,D 24 Vascular outcomes,1,1
CA Clinical,D 24 Vascular outcomes,1,1
CA Clinical,D 24 Vascular outcomes,1,1
CA Clinical,D 24 Vascular outcomes,1,1
CA Physiological,D 24 Vascular outcomes,1,1
CA Clinical,D 24 Vascular outcomes,1,1
CA Clinical,D 24 Vascular outcomes,1,1
CA Physiological,D 24 Vascular outcomes,1,1
CA Clinical,D 24 Vascular outcomes,1,1
CA Clinical,D 24 Vascular outcomes,1,1
CA Clinical,D 24 Vascular outcomes,1,1
CA Life impact,D 25 Physical functioning,1,1
CA Life impact,D 25 Physical functioning,1,1
CA Life impact,D 30 Global quality of life,1,1
CA Life impact,D 32 Delivery of care,1,1
CA Life impact,D 32 Delivery of care,1,1
CA Life impact,D 32 Delivery of care,1,1
CA Life impact,D 32 Delivery of care,1,1
CA Life impact,D 32 Delivery of care,1,1
CA Life impact,D 32 Delivery of care,1,1
CA Life impact,D 32 Delivery of care,1,1
CA Life impact,D 32 Delivery of care,1,1
CA Life impact,D 32 Delivery of care,1,1
CA Life impact,D 32 Delivery of care,1,1
CA Resource use,D 34 Economic,1,1
CA Resource use,D 35 Hospital,1,1
CA Resource use,D 35 Hospital,1,1
CA Life impact,D 35 Hospital,1,1
CA Resource use,D 35 Hospital,1,1
CA Resource use,D 35 Hospital,1,1
CA Resource use,D 35 Hospital,1,1
CA Resource use,D 35 Hospital,1,1
CA Resource use,D 35 Hospital,1,1
CA Life impact,D 35 Hospital,1,1
CA Resource use,D 35 Hospital,1,1
CA Resource use,D 35 Hospital,1,1
CA Resource use,D 35 Hospital,1,1
CA Resource use,D 35 Hospital,1,1
CA Resource use,D 35 Hospital,1,1
CA Resource use,D 35 Hospital,1,1
CA Resource use,D 35 Hospital,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Resource use,D 36 Need for further intervention,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
CA Adverse events,D 38 Adverse events and effects,1,1
OM Adverse events,Demeyere et al (2010),1,1
OM Chest tube output,Demeyere et al (2010),1,1
OM Coagulation factors ,Demeyere et al (2010),1,1
OM HCT,Demeyere et al (2010),1,1
OM in vivo thrombin generation ,Demeyere et al (2010),1,1
OM Plasma,Demeyere et al (2010),1,1
OM RBC,Demeyere et al (2010),1,1
OM Reoperation,Demeyere et al (2010),1,1
OM Complete Blood Count,Etemadreziae et al (2007),1,1
OM Glascow Coma Scale,Etemadreziae et al (2007),1,1
OM INR,Etemadreziae et al (2007),1,1
OM Intracerebral hemorrhage,Etemadreziae et al (2007),1,1
OM Mortality,Etemadreziae et al (2007),1,1
OM Plasma thromboplastin time (PTT),Etemadreziae et al (2007),1,1
OM Reoperation,Etemadreziae et al (2007),1,1
OM aPTT,French et al (2003),1,1
OM Coagulation factors ,French et al (2003),1,1
OM Ddimers,French et al (2003),1,1
OM INR,French et al (2003),1,1
OM Pulmonary oedema,French et al (2003),1,1
OM Reptilase time,French et al (2003),1,1
OM aPTT,Garrigue et al (2017),1,1
OM arterial blood gas,Garrigue et al (2017),1,1
OM Coagulation factors ,Garrigue et al (2017),1,1
OM Fibrin monomer,Garrigue et al (2017),1,1
OM Fibrinogen,Garrigue et al (2017),1,1
OM Fluids,Garrigue et al (2017),1,1
OM Hemostatic agents,Garrigue et al (2017),1,1
OM LOS Hospital,Garrigue et al (2017),1,1
OM Plasma,Garrigue et al (2017),1,1
OM Platelets,Garrigue et al (2017),1,1
OM PT,Garrigue et al (2017),1,1
OM RBC,Garrigue et al (2017),1,1
OM Time to transfuion,Garrigue et al (2017),1,1
OM Adverse events,Goldstein et al (2015),1,1
OM Coagulation factors ,Goldstein et al (2015),1,1
OM Hemostatic efficacy,Goldstein et al (2015),1,1
OM INR,Goldstein et al (2015),1,1
OM Protein C and S,Goldstein et al (2015),1,1
OM RBC,Goldstein et al (2015),1,1
OM Whole Blood,Goldstein et al (2015),1,1
OM aPTT,Green et al (2020),1,1
OM Blood loss,Green et al (2020),1,1
OM Coagulation factors ,Green et al (2020),1,1
OM Consented and received intervention,Green et al (2020),1,1
OM Ddimers,Green et al (2020),1,1
OM Fibrinogen,Green et al (2020),1,1
OM Hemostatic agents,Green et al (2020),1,1
OM Other ,Green et al (2020),1,1
OM Plasma,Green et al (2020),1,1
OM Platelets,Green et al (2020),1,1
OM Protocol adherence,Green et al (2020),1,1
OM PTT,Green et al (2020),1,1
OM RBC,Green et al (2020),1,1
OM safety,Green et al (2020),1,1
OM Time from intervention to chest closure,Green et al (2020),1,1
OM Time to intervention,Green et al (2020),1,1
OM Adverse events,Innerhofer et al (2017),1,1
OM LOS ICU,Innerhofer et al (2017),1,1
OM Mortality,Innerhofer et al (2017),1,1
OM Need for massive transfusion,Innerhofer et al (2017),1,1
OM Reversal of coagulopathy,Innerhofer et al (2017),1,1
OM Adverse events,Jost et al (2022),1,1
OM arterial blood gas,Jost et al (2022),1,1
OM Coagulation factors ,Jost et al (2022),1,1
OM Complete Blood Count,Jost et al (2022),1,1
OM Feasibility,Jost et al (2022),1,1
OM Fibrinogen,Jost et al (2022),1,1
OM INR,Jost et al (2022),1,1
OM LOS Hospital,Jost et al (2022),1,1
OM LOS ICU,Jost et al (2022),1,1
OM Mortality ,Jost et al (2022),1,1
OM Need for massive transfusion,Jost et al (2022),1,1
OM Plasma,Jost et al (2022),1,1
OM plasma to crystalloid ratio,Jost et al (2022),1,1
OM Platelets,Jost et al (2022),1,1
OM PT,Jost et al (2022),1,1
OM RBC,Jost et al (2022),1,1
OM Survival ,Jost et al (2022),1,1
OM traceability ,Jost et al (2022),1,1
OM Transfusion reaction,Jost et al (2022),1,1
OM Urgent surgery,Jost et al (2022),1,1
OM Bleeding,Karkouti et al (2021),1,1
OM Blood loss,Karkouti et al (2021),1,1
OM Hemostatic agents,Karkouti et al (2021),1,1
OM Hemostatic efficacy,Karkouti et al (2021),1,1
OM Plasma,Karkouti et al (2021),1,1
OM Platelets,Karkouti et al (2021),1,1
OM RBC,Karkouti et al (2021),1,1
OM Bleeding,Lance et al (2012),1,1
OM Coagulation factors ,Lance et al (2012),1,1
OM Fibrinogen,Lance et al (2012),1,1
OM Prothrombin,Lance et al (2012),1,1
OM Thrombin generation,Lance et al (2012),1,1
OM Viscoelastic tests,Lance et al (2012),1,1
OM ACT,Massoumi G et al (2018),1,1
OM aPTT,Massoumi G et al (2018),1,1
OM Chest tube output,Massoumi G et al (2018),1,1
OM Complete Blood Count,Massoumi G et al (2018),1,1
OM Fibrinogen,Massoumi G et al (2018),1,1
OM PT,Massoumi G et al (2018),1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 36 Need for further intervention,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 36 Need for further intervention,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 38 Adverse events and effects,MC Adverse events,1,1
D 36 Need for further intervention,MC Adverse events,1,1
D 24 Vascular outcomes,MC Bleeding,1,1
D 24 Vascular outcomes,MC Bleeding,1,1
D 24 Vascular outcomes,MC Bleeding,1,1
D 24 Vascular outcomes,MC Bleeding,1,1
D 24 Vascular outcomes,MC Bleeding,1,1
D 24 Vascular outcomes,MC Bleeding,1,1
D 24 Vascular outcomes,MC Bleeding,1,1
D 24 Vascular outcomes,MC Bleeding,1,1
D 24 Vascular outcomes,MC Bleeding,1,1
D 24 Vascular outcomes,MC Bleeding,1,1
D 24 Vascular outcomes,MC Bleeding,1,1
D 24 Vascular outcomes,MC Bleeding,1,1
D 24 Vascular outcomes,MC Bleeding,1,1
D 2 Blood and lymphatic system outcomes,MC Bleeding,1,1
D 24 Vascular outcomes,MC Bleeding,1,1
D 24 Vascular outcomes,MC Bleeding,1,1
D 24 Vascular outcomes,MC Bleeding,1,1
D 24 Vascular outcomes,MC Bleeding,1,1
D 24 Vascular outcomes,MC Bleeding,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 36 Need for further intervention,MC Blood usage,1,1
D 32 Delivery of care,MC Feasibility,1,1
D 32 Delivery of care,MC Feasibility,1,1
D 32 Delivery of care,MC Feasibility,1,1
D 32 Delivery of care,MC Feasibility,1,1
D 32 Delivery of care,MC Feasibility,1,1
D 32 Delivery of care,MC Feasibility,1,1
D 2 Blood and lymphatic system outcomes,MC INR,1,1
D 2 Blood and lymphatic system outcomes,MC INR,1,1
D 2 Blood and lymphatic system outcomes,MC INR,1,1
D 2 Blood and lymphatic system outcomes,MC INR,1,1
D 2 Blood and lymphatic system outcomes,MC INR,1,1
D 2 Blood and lymphatic system outcomes,MC INR,1,1
D 2 Blood and lymphatic system outcomes,MC INR,1,1
D 2 Blood and lymphatic system outcomes,MC INR,1,1
D 2 Blood and lymphatic system outcomes,MC INR,1,1
D 2 Blood and lymphatic system outcomes,MC INR,1,1
D 2 Blood and lymphatic system outcomes,MC INR,1,1
D 2 Blood and lymphatic system outcomes,MC INR,1,1
D 2 Blood and lymphatic system outcomes,MC INR,1,1
D 35 Hospital,MC Length of stay,1,1
D 35 Hospital,MC Length of stay,1,1
D 35 Hospital,MC Length of stay,1,1
D 35 Hospital,MC Length of stay,1,1
D 35 Hospital,MC Length of stay,1,1
D 35 Hospital,MC Length of stay,1,1
D 35 Hospital,MC Length of stay,1,1
D 35 Hospital,MC Length of stay,1,1
D 35 Hospital,MC Length of stay,1,1
D 35 Hospital,MC Length of stay,1,1
D 35 Hospital,MC Length of stay,1,1
D 35 Hospital,MC Length of stay,1,1
D 35 Hospital,MC Length of stay,1,1
D 35 Hospital,MC Length of stay,1,1
D 35 Hospital,MC Length of stay,1,1
D 25 Physical functioning,MC Life impact,1,1
D 30 Global quality of life,MC Life impact,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 2 Blood and lymphatic system outcomes,MC Measures of coagulation,1,1
D 1 Mortality and Survival,MC Mortality,1,1
D 1 Mortality and Survival,MC Mortality,1,1
D 1 Mortality and Survival,MC Mortality,1,1
D 35 Hospital,MC Mortality,1,1
D 1 Mortality and Survival,MC Mortality,1,1
D 1 Mortality and Survival,MC Mortality,1,1
D 1 Mortality and Survival,MC Mortality,1,1
D 1 Mortality and Survival,MC Mortality,1,1
D 1 Mortality and Survival,MC Mortality,1,1
D 1 Mortality and Survival,MC Mortality,1,1
D 1 Mortality and Survival,MC Mortality,1,1
D 1 Mortality and Survival,MC Mortality,1,1
D 1 Mortality and Survival,MC Mortality,1,1
D 1 Mortality and Survival,MC Mortality,1,1
D 1 Mortality and Survival,MC Mortality,1,1
D 36 Need for further intervention,MC Need for additional treatment,1,1
D 36 Need for further intervention,MC Need for additional treatment,1,1
D 36 Need for further intervention,MC Need for additional treatment,1,1
D 36 Need for further intervention,MC Need for additional treatment,1,1
D 36 Need for further intervention,MC Need for additional treatment,1,1
D 36 Need for further intervention,MC Need for additional treatment,1,1
D 36 Need for further intervention,MC Need for additional treatment,1,1
D 36 Need for further intervention,MC Need for additional treatment,1,1
D 36 Need for further intervention,MC Need for additional treatment,1,1
D 36 Need for further intervention,MC Need for additional treatment,1,1
D 36 Need for further intervention,MC Need for additional treatment,1,1
D 36 Need for further intervention,MC Need for additional treatment,1,1
D 25 Physical functioning,MC Organ specific treatment effect,1,1
D 17 Nervous system outcomes,MC Organ specific treatment effect,1,1
D 17 Nervous system outcomes,MC Organ specific treatment effect,1,1
D 24 Vascular outcomes,MC Organ specific treatment effect,1,1
D 17 Nervous system outcomes,MC Organ specific treatment effect,1,1
D 17 Nervous system outcomes,MC Organ specific treatment effect,1,1
D 32 Delivery of care,MC Organ specific treatment effect,1,1
D 32 Delivery of care,MC Other,1,1
D 32 Delivery of care,MC Other,1,1
D 34 Economic,MC Other,1,1
D 32 Delivery of care,MC Other,1,1
D 2 Blood and lymphatic system outcomes,MC Otherlaboratory measurements,1,1
D 2 Blood and lymphatic system outcomes,MC Otherlaboratory measurements,1,1
D 22 Respiratory thoracic and mediastinal outcomes,MC Otherlaboratory measurements,1,1
D 22 Respiratory thoracic and mediastinal outcomes,MC Otherlaboratory measurements,1,1
D 22 Respiratory thoracic and mediastinal outcomes,MC Otherlaboratory measurements,1,1
D 2 Blood and lymphatic system outcomes,MC Otherlaboratory measurements,1,1
D 2 Blood and lymphatic system outcomes,MC Otherlaboratory measurements,1,1
D 2 Blood and lymphatic system outcomes,MC Otherlaboratory measurements,1,1
D 2 Blood and lymphatic system outcomes,MC Otherlaboratory measurements,1,1
D 2 Blood and lymphatic system outcomes,MC Otherlaboratory measurements,1,1
D 2 Blood and lymphatic system outcomes,MC Otherlaboratory measurements,1,1
D 2 Blood and lymphatic system outcomes,MC Otherlaboratory measurements,1,1
D 2 Blood and lymphatic system outcomes,MC Otherlaboratory measurements,1,1
D 2 Blood and lymphatic system outcomes,MC Otherlaboratory measurements,1,1
D 2 Blood and lymphatic system outcomes,MC Otherlaboratory measurements,1,1
D 2 Blood and lymphatic system outcomes,MC Otherlaboratory measurements,1,1
D 24 Vascular outcomes,MC Otherlaboratory measurements,1,1
D 2 Blood and lymphatic system outcomes,MC Otherlaboratory measurements,1,1
D 2 Blood and lymphatic system outcomes,MC Otherlaboratory measurements,1,1
D 2 Blood and lymphatic system outcomes,MC Otherlaboratory measurements,1,1
D 11 Immune system outcomes,MC Otherlaboratory measurements,1,1
D 2 Blood and lymphatic system outcomes,MC Otherlaboratory measurements,1,1
OM Adverse events,Moore et al (2018),1,1
OM arterial blood gas,Moore et al (2018),1,1
OM Coagulation factors ,Moore et al (2018),1,1
OM Fibrinogen,Moore et al (2018),1,1
OM Fluids,Moore et al (2018),1,1
OM Hemostatic agents,Moore et al (2018),1,1
OM INR,Moore et al (2018),1,1
OM Mortality,Moore et al (2018),1,1
OM Plasma,Moore et al (2018),1,1
OM Platelets,Moore et al (2018),1,1
OM RBC,Moore et al (2018),1,1
OM Time to RBCtransfusion,Moore et al (2018),1,1
OM Transfusion reaction,Moore et al (2018),1,1
OM Viscoelastic tests,Moore et al (2018),1,1
OM Adverse events,Morrison et al (2019),1,1
OM aPTT,Morrison et al (2019),1,1
OM Bleeding,Morrison et al (2019),1,1
OM Complete Blood Count,Morrison et al (2019),1,1
OM Fibrinogen,Morrison et al (2019),1,1
OM Fluids,Morrison et al (2019),1,1
OM INR,Morrison et al (2019),1,1
OM LOS Hospital,Morrison et al (2019),1,1
OM LOS ICU,Morrison et al (2019),1,1
OM Mortality,Morrison et al (2019),1,1
OM Plasma,Morrison et al (2019),1,1
OM Platelets,Morrison et al (2019),1,1
OM RBC,Morrison et al (2019),1,1
OM INR,Muller et al (2015),1,1
OM LOS ICU,Muller et al (2015),1,1
OM Lung injury,Muller et al (2015),1,1
OM Major bleeding,Muller et al (2015),1,1
OM Mortality,Muller et al (2015),1,1
MC Measures of coagulation,OM ACT,1,1
MC Adverse events,OM Adverse events,1,1
MC Adverse events,OM Adverse events,1,1
MC Adverse events,OM Adverse events,1,1
MC Adverse events,OM Adverse events,1,1
MC Adverse events,OM Adverse events,1,1
MC Adverse events,OM Adverse events,1,1
MC Adverse events,OM Adverse events,1,1
MC Adverse events,OM Adverse events,1,1
MC Adverse events,OM Adverse events,1,1
MC Adverse events,OM Adverse events,1,1
MC Adverse events,OM Adverse events,1,1
MC Adverse events,OM Adverse events,1,1
MC Adverse events,OM Adverse events,1,1
MC Adverse events,OM Adverse events,1,1
MC Adverse events,OM Adverse events,1,1
MC Adverse events,OM Adverse events,1,1
MC Measures of coagulation,OM aPTT,1,1
MC Measures of coagulation,OM aPTT,1,1
MC Measures of coagulation,OM aPTT,1,1
MC Measures of coagulation,OM aPTT,1,1
MC Measures of coagulation,OM aPTT,1,1
MC Measures of coagulation,OM aPTT,1,1
MC Measures of coagulation,OM aPTT,1,1
MC Measures of coagulation,OM aPTT,1,1
MC Measures of coagulation,OM aPTT,1,1
MC Otherlaboratory measurements,OM arterial blood gas,1,1
MC Otherlaboratory measurements,OM arterial blood gas,1,1
MC Otherlaboratory measurements,OM arterial blood gas,1,1
MC Otherlaboratory measurements,OM arterial blood gas,1,1
MC Measures of coagulation,OM ATIII,1,1
MC Blood usage,OM Avoidance of allogeneic transfusion,1,1
MC Life impact,OM Barthel Index,1,1
MC Bleeding,OM Bleeding,1,1
MC Bleeding,OM Bleeding,1,1
MC Bleeding,OM Bleeding,1,1
MC Bleeding,OM Bleeding,1,1
MC Bleeding,OM Blood loss,1,1
MC Bleeding,OM Blood loss,1,1
MC Bleeding,OM Blood loss,1,1
MC Bleeding,OM Blood loss,1,1
MC Bleeding,OM Blood loss,1,1
MC Bleeding,OM Blood loss,1,1
MC Bleeding,OM Chest tube output,1,1
MC Bleeding,OM Chest tube output,1,1
MC Bleeding,OM Chest tube output,1,1
MC Measures of coagulation,OM Coagulation factors ,1,1
MC Measures of coagulation,OM Coagulation factors ,1,1
MC Measures of coagulation,OM Coagulation factors ,1,1
MC Measures of coagulation,OM Coagulation factors ,1,1
MC Measures of coagulation,OM Coagulation factors ,1,1
MC Measures of coagulation,OM Coagulation factors ,1,1
MC Measures of coagulation,OM Coagulation factors ,1,1
MC Measures of coagulation,OM Coagulation factors ,1,1
MC Measures of coagulation,OM Coagulation factors ,1,1
MC Measures of coagulation,OM Coagulation factors ,1,1
MC Measures of coagulation,OM Coagulation factors ,1,1
MC Otherlaboratory measurements,OM Complement,1,1
MC Bleeding,OM Complete Blood Count,1,1
MC Otherlaboratory measurements,OM Complete Blood Count,1,1
MC Otherlaboratory measurements,OM Complete Blood Count,1,1
MC Otherlaboratory measurements,OM Complete Blood Count,1,1
MC Otherlaboratory measurements,OM Complete Blood Count,1,1
MC Otherlaboratory measurements,OM Complete Blood Count,1,1
MC Otherlaboratory measurements,OM Complete Blood Count,1,1
MC Otherlaboratory measurements,OM Complete Blood Count,1,1
MC Otherlaboratory measurements,OM Complete Blood Count,1,1
MC Otherlaboratory measurements,OM Complete Blood Count,1,1
MC Other,OM Consented and received intervention,1,1
MC Measures of coagulation,OM Ddimers,1,1
MC Measures of coagulation,OM Ddimers,1,1
MC Mortality,OM Death,1,1
MC Mortality,OM Death,1,1
MC Mortality,OM Death,1,1
MC Other,OM Donor exposure,1,1
MC Other,OM Economic impact ,1,1
MC Otherlaboratory measurements,OM Electrolytes,1,1
MC Otherlaboratory measurements,OM Endothelial markers,1,1
MC Organ specific treatment effect,OM Extended Glasgow Outcome Scale ,1,1
MC Feasibility,OM Feasibility,1,1
MC Feasibility,OM Feasibility,1,1
MC Blood usage,OM FFP,1,1
MC Measures of coagulation,OM Fibrin monomer,1,1
MC Measures of coagulation,OM Fibrinogen,1,1
MC Measures of coagulation,OM Fibrinogen,1,1
MC Measures of coagulation,OM Fibrinogen,1,1
MC Measures of coagulation,OM Fibrinogen,1,1
MC Measures of coagulation,OM Fibrinogen,1,1
MC Measures of coagulation,OM Fibrinogen,1,1
MC Measures of coagulation,OM Fibrinogen,1,1
MC Measures of coagulation,OM Fibrinogen,1,1
MC Measures of coagulation,OM Fibrinogen,1,1
MC Measures of coagulation,OM Fibrinogen,1,1
MC Measures of coagulation,OM Fibrinogen,1,1
MC Need for additional treatment,OM Fluids,1,1
MC Need for additional treatment,OM Fluids,1,1
MC Need for additional treatment,OM Fluids,1,1
MC Need for additional treatment,OM Fluids,1,1
MC Need for additional treatment,OM Fluids,1,1
MC Adverse events,OM General,1,1
MC Organ specific treatment effect,OM Glascow Coma Scale,1,1
MC Otherlaboratory measurements,OM HCT,1,1
MC Otherlaboratory measurements,OM HCT,1,1
MC Need for additional treatment,OM Hemostatic agents,1,1
MC Need for additional treatment,OM Hemostatic agents,1,1
MC Need for additional treatment,OM Hemostatic agents,1,1
MC Need for additional treatment,OM Hemostatic agents,1,1
MC Need for additional treatment,OM Hemostatic agents,1,1
MC Need for additional treatment,OM Hemostatic agents,1,1
MC Need for additional treatment,OM Hemostatic agents,1,1
MC Bleeding,OM Hemostatic efficacy,1,1
MC Bleeding,OM Hemostatic efficacy,1,1
MC Bleeding,OM Hemostatic efficacy,1,1
MC Otherlaboratory measurements,OM in vivo thrombin generation ,1,1
MC Otherlaboratory measurements,OM Inflammation markers,1,1
MC INR,OM INR,1,1
MC INR,OM INR,1,1
MC INR,OM INR,1,1
MC INR,OM INR,1,1
MC INR,OM INR,1,1
MC INR,OM INR,1,1
MC INR,OM INR,1,1
MC INR,OM INR,1,1
MC INR,OM INR,1,1
MC INR,OM INR,1,1
MC INR,OM INR,1,1
MC Measures of coagulation,OM INR,1,1
MC INR,OM INR,1,1
MC INR,OM INR,1,1
MC Organ specific treatment effect,OM Intracerebral hemorrhage,1,1
MC Organ specific treatment effect,OM Intracerebral hemorrhage,1,1
MC Length of stay,OM Lenght of hospital stay,1,1
MC Length of stay,OM LOS Hospital,1,1
MC Length of stay,OM LOS Hospital,1,1
MC Length of stay,OM LOS Hospital,1,1
MC Length of stay,OM LOS Hospital,1,1
MC Length of stay,OM LOS Hospital,1,1
MC Mortality,OM LOS Hospital,1,1
MC Length of stay,OM LOS ICU,1,1
MC Length of stay,OM LOS ICU,1,1
MC Length of stay,OM LOS ICU,1,1
MC Length of stay,OM LOS ICU,1,1
MC Length of stay,OM LOS ICU,1,1
MC Length of stay,OM LOS ICU,1,1
MC Length of stay,OM LOS ICU,1,1
MC Length of stay,OM LOS ICU,1,1
MC Length of stay,OM LOS PICU,1,1
MC Adverse events,OM Lung injury,1,1
MC Bleeding,OM Major bleeding,1,1
MC Bleeding,OM Major bleeding,1,1
MC Mortality,OM Mortality,1,1
MC Mortality,OM Mortality,1,1
MC Mortality,OM Mortality,1,1
MC Mortality,OM Mortality,1,1
MC Mortality,OM Mortality,1,1
MC Mortality,OM Mortality,1,1
MC Mortality,OM Mortality,1,1
MC Mortality,OM Mortality,1,1
MC Mortality,OM Mortality,1,1
MC Mortality,OM Mortality ,1,1
MC Organ specific treatment effect,OM mRS score,1,1
MC Organ specific treatment effect,OM National Institute of Health Stroke Scale,1,1
MC Blood usage,OM Need for massive transfusion,1,1
MC Blood usage,OM Need for massive transfusion,1,1
MC Measures of coagulation,OM Other ,1,1
MC Blood usage,OM Plasma,1,1
MC Blood usage,OM Plasma,1,1
MC Blood usage,OM Plasma,1,1
MC Blood usage,OM Plasma,1,1
MC Blood usage,OM Plasma,1,1
MC Blood usage,OM Plasma,1,1
MC Blood usage,OM Plasma,1,1
MC Blood usage,OM Plasma,1,1
MC Blood usage,OM Plasma,1,1
MC Blood usage,OM Plasma,1,1
MC Blood usage,OM Plasma,1,1
MC Blood usage,OM Plasma,1,1
MC Blood usage,OM Plasma,1,1
MC Blood usage,OM Plasma,1,1
MC Measures of coagulation,OM Plasma thromboplastin time (PTT),1,1
MC Blood usage,OM plasma to crystalloid ratio,1,1
MC Blood usage,OM Platelets,1,1
MC Blood usage,OM Platelets,1,1
MC Blood usage,OM Platelets,1,1
MC Blood usage,OM Platelets,1,1
MC Blood usage,OM Platelets,1,1
MC Blood usage,OM Platelets,1,1
MC Blood usage,OM Platelets,1,1
MC Blood usage,OM Platelets,1,1
MC Blood usage,OM Platelets,1,1
MC Blood usage,OM Platelets,1,1
MC Blood usage,OM Platelets,1,1
MC Blood usage,OM Platelets,1,1
MC Blood usage,OM Platelets,1,1
MC Measures of coagulation,OM Protein C and S,1,1
MC Measures of coagulation,OM Protein C and S,1,1
MC Measures of coagulation,OM Prothrombin,1,1
MC Other,OM Protocol adherence,1,1
MC Measures of coagulation,OM PT,1,1
MC Measures of coagulation,OM PT,1,1
MC Measures of coagulation,OM PT,1,1
MC Measures of coagulation,OM PT,1,1
MC Measures of coagulation,OM PT,1,1
MC Measures of coagulation,OM PT,1,1
MC Measures of coagulation,OM PTT,1,1
MC Measures of coagulation,OM PTT,1,1
MC Measures of coagulation,OM PTT,1,1
MC Adverse events,OM Pulmonary oedema,1,1
MC Life impact,OM Quality of life,1,1
MC Blood usage,OM RBC,1,1
MC Blood usage,OM RBC,1,1
MC Blood usage,OM RBC,1,1
MC Blood usage,OM RBC,1,1
MC Blood usage,OM RBC,1,1
MC Blood usage,OM RBC,1,1
MC Blood usage,OM RBC,1,1
MC Blood usage,OM RBC,1,1
MC Blood usage,OM RBC,1,1
MC Blood usage,OM RBC,1,1
MC Blood usage,OM RBC,1,1
MC Blood usage,OM RBC,1,1
MC Blood usage,OM RBC,1,1
MC Blood usage,OM RBC,1,1
MC Blood usage,OM RBC,1,1
MC Blood usage,OM RBC,1,1
MC Adverse events,OM renal failure,1,1
MC Adverse events,OM Reoperation,1,1
MC Adverse events,OM Reoperation,1,1
MC Adverse events,OM Reoperation,1,1
MC Adverse events,OM Reoperation,1,1
MC Otherlaboratory measurements,OM Reptilase time,1,1
MC Measures of coagulation,OM Reversal of coagulopathy,1,1
MC Adverse events,OM safety,1,1
MC Mortality,OM Survival ,1,1
MC Measures of coagulation,OM Thrombin generation,1,1
MC Otherlaboratory measurements,OM Thromboelastography ,1,1
MC Organ specific treatment effect,OM Time from intervention to chest closure,1,1
MC Feasibility,OM Time to intervention,1,1
MC Feasibility,OM Time to RBCtransfusion,1,1
MC Feasibility,OM Time to transfuion,1,1
MC Feasibility,OM traceability ,1,1
MC Adverse events,OM Transfusion reaction,1,1
MC Adverse events,OM Transfusion reaction,1,1
MC Adverse events,OM Transfusion reaction,1,1
MC Adverse events,OM Transfusion reaction,1,1
MC Adverse events,OM Transfusion reaction,1,1
MC Adverse events,OM Transfusion reaction,1,1
MC Adverse events,OM Urgent surgery,1,1
MC Measures of coagulation,OM Viscoelastic tests,1,1
MC Measures of coagulation,OM Viscoelastic tests,1,1
MC Measures of coagulation,OM Viscoelastic tests,1,1
MC Measures of coagulation,OM Viscoelastic tests,1,1
MC Blood usage,OM Whole Blood,1,1
MC Blood usage,OM Whole Blood,1,1
OM arterial blood gas,Pieters et al (2015),1,1
OM Blood loss,Pieters et al (2015),1,1
OM Donor exposure,Pieters et al (2015),1,1
OM Electrolytes,Pieters et al (2015),1,1
OM Fibrinogen,Pieters et al (2015),1,1
OM Fluids,Pieters et al (2015),1,1
OM Hemostatic agents,Pieters et al (2015),1,1
OM LOS Hospital,Pieters et al (2015),1,1
OM LOS PICU,Pieters et al (2015),1,1
OM Plasma,Pieters et al (2015),1,1
OM Platelets,Pieters et al (2015),1,1
OM PT,Pieters et al (2015),1,1
OM PTT,Pieters et al (2015),1,1
OM RBC,Pieters et al (2015),1,1
OM Adverse events,Sarode et al (2013),1,1
OM Coagulation factors ,Sarode et al (2013),1,1
OM Death,Sarode et al (2013),1,1
OM Hemostatic efficacy,Sarode et al (2013),1,1
OM INR,Sarode et al (2013),1,1
OM Protein C and S,Sarode et al (2013),1,1
OM Adverse events,Smith et al (2022),1,1
OM aPTT,Smith et al (2022),1,1
OM Avoidance of allogeneic transfusion,Smith et al (2022),1,1
OM Chest tube output,Smith et al (2022),1,1
OM Complete Blood Count,Smith et al (2022),1,1
OM Fibrinogen,Smith et al (2022),1,1
OM Hemostatic agents,Smith et al (2022),1,1
OM INR,Smith et al (2022),1,1
OM LOS Hospital,Smith et al (2022),1,1
OM LOS ICU,Smith et al (2022),1,1
OM Mortality,Smith et al (2022),1,1
OM Plasma,Smith et al (2022),1,1
OM Platelets,Smith et al (2022),1,1
OM PT,Smith et al (2022),1,1
OM RBC,Smith et al (2022),1,1
OM Reoperation,Smith et al (2022),1,1
OM Adverse events,Sperry et al (2018),1,1
OM Fluids,Sperry et al (2018),1,1
OM Mortality,Sperry et al (2018),1,1
OM Plasma,Sperry et al (2018),1,1
OM Platelets,Sperry et al (2018),1,1
OM PTT,Sperry et al (2018),1,1
OM RBC,Sperry et al (2018),1,1
OM Transfusion reaction,Sperry et al (2018),1,1
OM Viscoelastic tests,Sperry et al (2018),1,1
OM Adverse events,Steiner et al (2016),1,1
OM Barthel Index,Steiner et al (2016),1,1
OM Death,Steiner et al (2016),1,1
OM Extended Glasgow Outcome Scale ,Steiner et al (2016),1,1
OM Feasibility,Steiner et al (2016),1,1
OM INR,Steiner et al (2016),1,1
OM Intracerebral hemorrhage,Steiner et al (2016),1,1
OM mRS score,Steiner et al (2016),1,1
OM National Institute of Health Stroke Scale,Steiner et al (2016),1,1
OM Quality of life,Steiner et al (2016),1,1
OM Adverse events,Stensballe et al (2018),1,1
OM Bleeding,Stensballe et al (2018),1,1
OM Economic impact ,Stensballe et al (2018),1,1
OM Endothelial markers,Stensballe et al (2018),1,1
OM Hemostatic agents,Stensballe et al (2018),1,1
OM Inflammation markers,Stensballe et al (2018),1,1
OM LOS Hospital,Stensballe et al (2018),1,1
OM LOS ICU,Stensballe et al (2018),1,1
OM Mortality,Stensballe et al (2018),1,1
OM renal failure,Stensballe et al (2018),1,1
OM Transfusion reaction,Stensballe et al (2018),1,1
OM Blood loss,Tamura et al (2020),1,1
OM LOS ICU,Tamura et al (2020),1,1
OM Plasma,Tamura et al (2020),1,1
OM Platelets,Tamura et al (2020),1,1
OM RBC,Tamura et al (2020),1,1
OM Viscoelastic tests,Tamura et al (2020),1,1
OM Adverse events,Tollofsrud et al (2003),1,1
OM aPTT,Tollofsrud et al (2003),1,1
OM Complement,Tollofsrud et al (2003),1,1
OM General,Tollofsrud et al (2003),1,1
OM Plasma,Tollofsrud et al (2003),1,1
OM Platelets,Tollofsrud et al (2003),1,1
OM RBC,Tollofsrud et al (2003),1,1
OM Whole Blood,Tollofsrud et al (2003),1,1
OM Adverse events,Yiu et al (2006),1,1
OM INR,Yiu et al (2006),1,1
OM Major bleeding,Yiu et al (2006),1,1
OM Transfusion reaction,Yiu et al (2006),1,1
OM Adverse events,Zhang et al (20219),1,1
OM Complete Blood Count,Zhang et al (20219),1,1
OM Lenght of hospital stay,Zhang et al (20219),1,1
OM Mortality,Zhang et al (20219),1,1
